New cream offers hope for stubborn skin disease
NCT ID NCT06857240
Summary
This study is testing whether a topical cream called ruxolitinib is safe and effective for treating severe skin symptoms in adults with dermatomyositis, an autoimmune disease. The cream is being studied in 15 participants whose skin symptoms have not improved with other standard treatments. The goal is to see if applying this cream to affected skin areas can reduce inflammation and improve skin health without the side effects of long-term steroid creams.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
Contact
Conditions
Explore the condition pages connected to this study.